Mitsutaka Nakamura

1.8k total citations
60 papers, 1.5k citations indexed

About

Mitsutaka Nakamura is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Mitsutaka Nakamura has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 7 papers in Psychiatry and Mental health. Recurrent topics in Mitsutaka Nakamura's work include Neuroscience and Neuropharmacology Research (23 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Receptor Mechanisms and Signaling (7 papers). Mitsutaka Nakamura is often cited by papers focused on Neuroscience and Neuropharmacology Research (23 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Receptor Mechanisms and Signaling (7 papers). Mitsutaka Nakamura collaborates with scholars based in Japan, United States and Pakistan. Mitsutaka Nakamura's co-authors include Hideaki Fukushima, Masaaki Ogasa, Akira Hirose, Hiroshi Shimizu, Hiroyasu Tanaka, Tohru Tatsuno, John Guarino, Yukihiro Ohno, Junki Katsube and Tadashi Ishibashi and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Mitsutaka Nakamura

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsutaka Nakamura Japan 20 725 567 373 189 146 60 1.5k
Anton A. H. P. Megens Belgium 22 878 1.2× 613 1.1× 653 1.8× 223 1.2× 114 0.8× 45 1.9k
David J. Brunswick United States 27 857 1.2× 424 0.7× 607 1.6× 418 2.2× 126 0.9× 70 1.9k
R J Baldessarini United States 28 946 1.3× 566 1.0× 746 2.0× 229 1.2× 99 0.7× 62 2.1k
Philip Seeman Canada 14 779 1.1× 865 1.5× 556 1.5× 161 0.9× 102 0.7× 16 1.7k
Shaun Jordan United States 14 589 0.8× 463 0.8× 298 0.8× 196 1.0× 93 0.6× 18 1.2k
Paul Van Gompel Belgium 15 1.3k 1.8× 616 1.1× 895 2.4× 214 1.1× 120 0.8× 26 2.1k
Roy Corbett United States 20 982 1.4× 287 0.5× 527 1.4× 133 0.7× 145 1.0× 34 1.5k
Katsura Tottori Japan 16 828 1.1× 1.1k 1.9× 637 1.7× 304 1.6× 108 0.7× 23 2.1k
H. Dekirmenjian United States 24 621 0.9× 464 0.8× 336 0.9× 338 1.8× 201 1.4× 47 1.7k
J. I. Javaid United States 20 627 0.9× 312 0.6× 344 0.9× 249 1.3× 97 0.7× 52 1.5k

Countries citing papers authored by Mitsutaka Nakamura

Since Specialization
Citations

This map shows the geographic impact of Mitsutaka Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsutaka Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsutaka Nakamura more than expected).

Fields of papers citing papers by Mitsutaka Nakamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsutaka Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsutaka Nakamura. The network helps show where Mitsutaka Nakamura may publish in the future.

Co-authorship network of co-authors of Mitsutaka Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsutaka Nakamura. A scholar is included among the top collaborators of Mitsutaka Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsutaka Nakamura. Mitsutaka Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okuno, Tomofumi, Teruyuki Nakao, Takumi Tsuji, et al.. (2012). Self-Improvement and Participatory Career Development Education Program: “Internship and Volunteer Experience Training for Pharmacy Students^|^quot; and its results. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 38(12). 757–766. 2 indexed citations
2.
Nakamura, Mitsutaka, Masaaki Ogasa, John Guarino, et al.. (2009). Lurasidone in the Treatment of Acute Schizophrenia. The Journal of Clinical Psychiatry. 70(6). 829–836. 164 indexed citations
3.
Nisijima, Koichi, et al.. (2002). Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex. Neurochemistry International. 40(4). 355–360. 35 indexed citations
4.
Ohtani, Ken-Ichi, Hiroyasu Tanaka, Yukio Yoneda, et al.. (2002). In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site. Brain Research. 944(1-2). 165–173. 14 indexed citations
5.
Ishibashi, Tadashi, et al.. (1999). Effects of Perospirone, a Novel 5-HT2 and D2 Receptor Antagonist, on Fos Protein Expression in the Rat Forebrain. Pharmacology Biochemistry and Behavior. 63(4). 535–541. 14 indexed citations
8.
Tanaka, Hiroyasu, et al.. (1995). Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain. General Pharmacology The Vascular System. 26(8). 1765–1772. 19 indexed citations
9.
Ishibashi, Tadashi, et al.. (1995). Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19(6). 1091–1101. 13 indexed citations
10.
Yoneda, Yukio, et al.. (1993). Excitatory amino acid receptor binding in hippocampus of gerbils with transient global brain ischemia. Brain Research. 613(1). 21–31. 5 indexed citations
11.
Shimizu, Hiroshi, et al.. (1992). Anticonflict Action of Tandospirone in a Modified Geller-Seifter Conflict Test in Rats.. The Japanese Journal of Pharmacology. 58(3). 283–289. 18 indexed citations
12.
Kato, Terufumi, Akira Hirose, Yukihiro Ohno, et al.. (1990). Binding Profile of SM-9018, a Novel Antipsychotic Candidate. The Japanese Journal of Pharmacology. 54(4). 478–481. 44 indexed citations
13.
Hirose, Akira, Terufumi Kato, Yukihiro Ohno, et al.. (1990). Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions. The Japanese Journal of Pharmacology. 53(3). 321–329. 51 indexed citations
14.
Tatsuno, Tohru, et al.. (1989). Effects of the putative anxiolytic SM-3997 on central monoaminergic systems. Pharmacology Biochemistry and Behavior. 32(4). 1049–1055. 20 indexed citations
15.
Shimizu, Hiroshi, et al.. (1988). Interaction of SM-3997 with Serotonin Receptors in Rat Brain. The Japanese Journal of Pharmacology. 46(3). 311–314. 7 indexed citations
16.
Shimizu, Hiroshi, et al.. (1988). Anti-conflict action of SM-3997 in the Geller-Seifter conflict paradigm in rats. The Japanese Journal of Pharmacology. 46. 170–170. 2 indexed citations
17.
Shimizu, Hiroshi, Akira Hirose, Tohru Tatsuno, Mitsutaka Nakamura, & Junki Katsube. (1987). Pharmacological properties of SM-3997: A new anxioselective anxiolytic candidate.. The Japanese Journal of Pharmacology. 45(4). 493–500. 72 indexed citations
18.
Shimizu, Hiroshi, Akira Hirose, Terufumi Kato, et al.. (1986). The mechanism of the pharmacological action of SM-3997: A new anxioselective anxiolytic agent. The Japanese Journal of Pharmacology. 40. 191–191. 10 indexed citations
19.
Kubota, Kinziro, Shigeru Komatsu, Mitsutaka Nakamura, & Toshiaki Masegi. (1980). Muscle spindle supply to the bovine jaw muscles. The Anatomical Record. 197(4). 413–422. 5 indexed citations
20.
Nakamura, Mitsutaka & Hideaki Fukushima. (1976). The effect of tricyclic antidepressants and neuroleptics on the peripheral and central action of norepinephrine in reserpine-treated mice. European Journal of Pharmacology. 38(2). 343–348. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026